Know your Chinese biotech competitors. Get real-time alerts.
Track clinical progress, deals, and approvals.
China has reached parity with the US in drug development - it's now a proven biotech powerhouse. That means new clinical milestones from Chinese competitors can reshape your landscape overnight.
Trial-Intel keeps you ahead. Powered by TrialWire's proprietary AI, it automatically monitors the clinical progress of any competing clinical-stage China biotech — extracting and analyzing data from trial registries, biotech media, news announcements, and corporate websites.
- Unlimited searches and tracking
- Real-time alerts
- Everything in one dashboard
Intelligence you can't afford to miss.
$200 / month · unlimited tracked competitors · dashboard & alerts
tracked.competitors / china
Akeso Inc.
Zhongshan · Bispecific Antibody
14
trials
Innovent Biologics
Suzhou · mAb, ADC, GLP-1
19
trials
Junshi Biosciences
Shanghai · Monoclonal Antibody
11
trials
Legend Biotech
Nanjing · CAR-T
8
trials
BeiGene
Beijing · Small Molecule, mAb, ADC
27
trials
last alert
Akeso · ivonescimab Phase 3 expanded to 690 pts — 2h ago
"One-third of the new drugs licensed by large US pharmaceutical companies are from China. A recent analysis shows that China now has gained parity with the US in drug development."
— Science, 2026
JUST A FEW OF THE SYNCED SOURCES
ChiCTRBioSpectrum AsiaANZCTREndpoints NewsFierce BiotechChina BiotechnologyPharmaTimes ChinaPlatform
The competitive intelligence layer for clinical-stage biotech.
Every registry, one search
Unified queries across ClinicalTrials.gov, ChiCTR and ANZCTR — with sponsor, phase, indication and site-level detail.
Auto-tracked competitors
Pin a company once. We re-scan every 6h, diff against the last snapshot, and surface what's new.
China-aware news feed
Endpoints, Fierce Biotech, BioCentury, PharmaTimes China and Yicai Global — filtered to your watchlist.
Email alerts that matter
Get an email the moment a tracked competitor opens a new site, shifts a primary completion date or hits the press.
Site-level geography
See exactly where trials are being run — country, city and investigator counts mapped at a glance.
Built for clinical teams
Magic-link sign-in, SOC2-ready hosting, audit trail of every alert delivered.
Example dashboard
5 Chinese biotechs. 79 active trials.
A snapshot of the demo dashboard you can create on day one. Trial-Intel finds competing studies and clinical data for live tracking and real-time alerts..
Akeso Inc.
NCT06532145 · ClinicalTrials.gov
Innovent Biologics
ChiCTR2500098123 · ChiCTR
Junshi Biosciences
NCT05891234 · ClinicalTrials.gov
Legend Biotech / J&J
NCT05985721 · ClinicalTrials.gov
BeiGene
NCT06112099 · ClinicalTrials.gov
Data sources
Built on the data clinical teams already trust.
Just some of the data registries we monitor:
ClinicalTrials.gov
Global
ChiCTR
China
ANZCTR
Australia / NZ
WHO ICTRP
Global
EU CTIS / EudraCT
Europe
ISRCTN
Global
jRCT
Japan
FDA — Drugs@FDA
USA
FDA — openFDA
USA
FDA — Orange Book
USA
EMA
Europe
MHRA
UK
PubMed / MEDLINE
Global
GRID / ROR
Global
NPI Registry
USA
CMS Open Payments
USA
CDC WONDER
USA
SEER
USA
GBD / IHME
Global
Eurostat
Europe
WHO GHO
Global
US Census / ACS
USA
County Health Rankings
USA
BIO / Informa Phase-Transition Benchmarks
Global
TransCelerate Metrics
Global
SDOH Datasets
Global
Media intelligence
More than 350 media outlets tracked in China & USA
TriaI-Intel monitors the biotech press, finance wires and local news that competitors surface in first — so you see the story before it becomes consensus. Media outlets include:
Endpoints News
USA
Fierce Biotech
USA
Fierce Pharma
USA
STAT News
USA
BioPharma Dive
USA
China Biotechnology
China
BioSpectrum Asia
Asia-Pacific
PharmaTimes China
China
Yicai Global
China
Sina Finance
China
21st Century Business Herald
China
Caixin Global
China
Plus 338+ additional outlets across English and Mandarin-language press.
Pricing
One price. Unlimited intelligence.
Professional
Billed monthly. Cancel anytime.
- Unlimited tracked competitors
- Unlimited dashboard searches
- Auto re-scan every 6 hours
- Email alerts on every change
- ClinicalTrials.gov + ChiCTR + ANZCTR
- Endpoints, Fierce, BioCentury news feed
- Magic-link sign-in (no passwords)
STRIPE SECURE CHECKOUT · CANCEL ANYTIME
- 1After your secure Stripe payment you will be redirected to your secure login
- 2Access your Dashboard
- 3Add your study ClinicalTrials.Gov link or TA or therapy search terms and build your tracking Dashboard instantly
FAQ
Questions, answered.
How fresh is the data?
ClinicalTrials.gov is polled live; ChiCTR and ANZCTR snapshots refresh every 6 hours. You get an email the moment a tracked competitor changes.
Do I need a Stripe / corporate card?
Sign-in is a magic link to your work email. Billing happens through Stripe ($200/month).
Can I add registries beyond China?
Yes — EU CTIS, Japan jRCT, India CTRI and KCT are on the roadmap. Vote in-app and we'll prioritise.